|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2535354 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12170052.0 |
| Date of filing the European patent application | 2008-06-13 | |
| (97) | Date of publication of the European application | 2012-12-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 944583 P | 2007-06-18 | US |
| (72) |
Carven, Gregory John, US
Van Eenennaam, Hans, NL
Dulos, Gradus Johannes, NL
|
| (73) |
Merck Sharp & Dohme B.V.,
Waarderweg 39, 2031 BN Haarlem,
NL
|
| (54) | ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 |
| ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 |